{"metadata":{"topics":["Access control","Accountability","Administrative law","Agencies of the United States government","Agreements","American law","American political philosophy","Applications of cryptography","Applied ethics","Artificial objects","Authentication","Authentication methods","Biometrics","Business","Business law","Business organizations","Chief executive officer","Civil law (common law)","Civil law (legal system)","Civil rights and liberties","Common law","Communication","Communication design","Companies","Comparative law","Computer access control","Computer data","Computer law","Computer security","Computing","Constitutional amendments","Constitutional law","Contract law","Control (social and political)","Controlled Substances Act","Corporate governance","Corporate law","Corporations","Courts","Crime","Criminal law","Cryptography","Cultural globalization","Cultural politics","Culture","Cyberspace","Cyberwarfare","Data","Data laws","Data management","Digital technology","Diplomacy","Documents","Economic law","Economy","Economy of the United States","Email","Environmental law","Espionage techniques","Ethical principles","Executive branch of the United States government","Fax","Federal republics","Federalism","Finance","Financial economics","Financial markets","Financial services","Foreign policy","Global politics","Government","Government  of the United States","Government agencies","Government and personhood","Government finances","Government information","Government institutions","Government of South Africa","Government of the United States","Human activities","Human communication","Human rights","Human rights concepts","Identification","Identifiers","Identity documents","Identity management","Identity politics","Individualism","Information governance","Information privacy","Information retrieval","Information science","Information technology","Information technology management","Intellectual property law","Intellectual works","International law","International relations","Investment","Investor","Judiciaries","Jurisprudence","Justice","Law","Law and economics","Law enforcement","Law enforcement techniques","Law of obligations","Lawsuits","Legal concepts","Legal disputes","Legal doctrines and principles","Legal documents","Legal ethics","Legal literature","Legal procedure","Legal writing","Legislative branch of the United States government","Love","Management","Market (economics)","Monopoly (economics)","Morality","Names","National legislatures","National security","Natural resources law","North America","Notary","Notation","Official documents","Open government","PDF","Personal identification","Personality traits","Political charters","Political economy","Political science","Political theories","Politics","Politics of the United States","Principles","Privacy","Privacy law","Private law","Professional ethics","Property","Property law","Public administration","Public law","Public policy","Public records","Public sphere","Regulation","Rights","Roman law","Secrecy","Secure communication","Securities (finance)","Security","Security technology","Semiotics","Separation of powers","Service industries","Signature","Social institutions","Social issues","Sociological theories","Sources","Sources of law","South African law","State constitutions of the United States","Statutory law","Symbols","Taxation","Technology","Telecommunications law","Treaties","United States","United States Constitution","United States criminal law","United States criminal legislation","United States economic policy","United States federal criminal law","United States federal criminal legislation","United States federal law","United States federal legislation","United States federal policy","United States law","United States lawsuits","United States legislation","United States public law","Value (ethics)","Virtue","Waiver","Writing","Written communication"],"person_names":["david c. robinson","robert kessler"],"vars":{},"organization_names":["biotex pharma investments","e c i t","inc.","lead investor","techniscan","techniscan inc."],"agreement_id":"7d8fcd4ca0bb158002f15605e0b0c2eacd8830a4c584979c81675915ba75f0ec","terms":["* *","**.*","**AMENDMENT**","**BIOTEX PHARMA INVESTMENTS**","**IN WITNESS WHEREOF**","**NOW, THEREFORE,**","**REGISTRATION RIGHTS AGREEMENT**","**TECHNISCAN, INC**","**TECHNISCAN, INC.**","**THIS AMENDMENT TO REGISTRATION RIGHTS AGREEMENT**","**TO**","**WHEREAS,**","**th*","**th**","*The number 105**","*The number 45**","*shall be deleted and replaced with the number 165**","“***Effectiveness Deadline***”","“***Filing Deadline***”","“Agreement”","“Amendment”","“Issuer”","“Lead Investor”"]}}